NASDAQ
XBiotech Inc. (XBIT)
♥ 590 Thanks from members
XBiotech Inc. (XBIT) displays cautious sentiment, driven by lower R&D expenses and a Phase II trial for vilamakitug, offset by ongoing net losses, zero revenue, and four consecutive quarters of institutional selling.